Company: PGEN
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001356090-25-000024
Chunk: 13

Company: PRECIGEN, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
Item 1. Condensed Consolidated Financial Statements

Precigen, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)

(Amounts in thousands, except share data)June 30,2025December 31,2024AssetsCurrent assetsCash and cash equivalents$13,760 $29,517 Short-term investments45,993 68,393 ReceivablesTrade, less allowance for credit losses of $0 as of both June 30, 2025 and December 31, 2024327 926 Other244 237 Prepaid expenses 2,431 3,341 Total current assets62,755 102,414 Property, plant and equipment, net14,695 13,831 Intangible assets, net3,818 4,455 Goodwill15,232 19,139 Right-of-use assets4,806 5,056 Other assets590 371 Total assets$101,896 $145,266 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Table of Contents

Precigen, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited) 

(Amounts in thousands, except share data)June 30,2025December 31,2024Liabilities, Mezzanine Equity and Shareholders' (Deficit) EquityCurrent liabilitiesAccounts payable$3,922 $3,531 Accrued compensation and benefits5,201 8,417 Other accrued liabilities9,514 4,812 Indemnification accruals3,213 3,213 Deferred revenue413 589 Current portion of lease liabilities930 956 Total current liabilities23,193 21,518 Deferred revenue, net of current portion1,818 1,934 Lease liabilities, net of current portion4,223 4,546 Warrant liabilities78,558 50,537 Total liabilities107,792 78,535 Commitments and contingencies (Note 13)Mezzanine equitySeries A Preferred Stock, no par value, 81,000 shares authorized as of June 30, 2025 and December 31, 2024; 79,000 shares issued as of as June 30, 2025 and December 31, 2024 (aggregate liquidation preference of $82,160 as